Literature DB >> 8226473

Human muscle metabolism during intermittent maximal exercise.

G C Gaitanos1, C Williams, L H Boobis, S Brooks.   

Abstract

Eight male subjects volunteered to take part in this study. The exercise protocol consisted of ten 6-s maximal sprints with 30 s of recovery between each sprint on a cycle ergometer. Needle biopsy samples were taken from the vastus lateralis muscle before and after the first sprint and 10 s before and immediately after the tenth sprint. The energy required to sustain the high mean power output (MPO) that was generated over the first 6-s sprint (870.0 +/- 159.2 W) was provided by an equal contribution from phosphocreatine (PCr) degradation and anaerobic glycolysis. Indeed, within the first 6-s bout of maximal exercise PCr concentration had fallen by 57% and muscle lactate concentration had increased to 28.6 mmol/kg dry wt, confirming significant glycolytic activity. However, in the tenth sprint there was no change in muscle lactate concentration even though MPO was reduced only to 73% of that generated in the first sprint. This reduced glycogenolysis occurred despite the high plasma epinephrine concentration of 5.1 +/- 1.5 nmol/l after sprint 9. In face of a considerable reduction in the contribution of anaerobic glycogenolysis to ATP production, it was suggested that, during the last sprint, power output was supported by energy that was mainly derived from PCr degradation and an increased aerobic metabolism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226473     DOI: 10.1152/jappl.1993.75.2.712

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  200 in total

Review 1.  Interval training for performance: a scientific and empirical practice. Special recommendations for middle- and long-distance running. Part II: anaerobic interval training.

Authors:  L V Billat
Journal:  Sports Med       Date:  2001-02       Impact factor: 11.136

Review 2.  The relationship between aerobic fitness and recovery from high intensity intermittent exercise.

Authors:  D L Tomlin; H A Wenger
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 3.  The scientific basis for high-intensity interval training: optimising training programmes and maximising performance in highly trained endurance athletes.

Authors:  Paul B Laursen; David G Jenkins
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 4.  Neural control of force output during maximal and submaximal exercise.

Authors:  A St Clair Gibson; M L Lambert; T D Noakes
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 5.  Long-term metabolic and skeletal muscle adaptations to short-sprint training: implications for sprint training and tapering.

Authors:  A Ross; M Leveritt
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

6.  Influence of two pedalling rate conditions on mechanical output and physiological responses during all-out intermittent exercise.

Authors:  Sylvain Dorel; Muriel Bourdin; Emmanuel Van Praagh; Jean-René Lacour; Christophe André Hautier
Journal:  Eur J Appl Physiol       Date:  2003-01-31       Impact factor: 3.078

7.  Catecholamine responses to high intensity cycle ergometer exercise: body mass or body composition?

Authors:  J S Baker; D M Bailey; J Dutton; B Davies
Journal:  J Physiol Biochem       Date:  2003-06       Impact factor: 4.158

8.  Performance for short intermittent runs: active recovery vs. passive recovery.

Authors:  Grégory Dupont; Nicolas Blondel; Serge Berthoin
Journal:  Eur J Appl Physiol       Date:  2003-05-07       Impact factor: 3.078

9.  Muscle buffer capacity and aerobic fitness are associated with repeated-sprint ability in women.

Authors:  David Bishop; Johann Edge; Carmel Goodman
Journal:  Eur J Appl Physiol       Date:  2004-08       Impact factor: 3.078

10.  Metabolic stress-dependent regulation of the mitochondrial biogenic molecular response to high-intensity exercise in human skeletal muscle.

Authors:  M Fiorenza; T P Gunnarsson; M Hostrup; F M Iaia; F Schena; H Pilegaard; J Bangsbo
Journal:  J Physiol       Date:  2018-06-26       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.